Netherlands· NL-7de090e4ec80

Capecitabine CF 500 mg, filmomhulde tabletten

A capecitabine product containing capecitabine, registered in Netherlands by Centrafarm B.V.. The same ATC class is registered in 17 of our 19 countries.

ATC L01BC06

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about capecitabineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Capecitabine is registered in 17 of 19 countries.

Countries holding a registration under ATC L01BC06 (capecitabine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
10 of them publish a price we can compare per daily dose

Search capecitabine products by name

Capecitabine · ATC L01BC06

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of capecitabine costs, country by country.

Normalised to the WHO defined daily dose (3 g), the median price runs from $2.73 in United States to $15.27 in Switzerland — a ×5.6 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Capecitabine · price per daily dose (3 g)

USD · FX 28 Sept 2026

CH Switzerland$15.27
IT Italy$12.14
FR France$8.39
US United States$2.73 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: CAPECITABINE
Manufacturer: Centrafarm B.V.
Country: Netherlands (NL)
ATC code: L01BC06
ATC class: Capecitabine
Defined daily dose: 3 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
109393

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

366 interactions on record for capecitabine.

Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check capecitabine against other medicines How interaction checks work

Capecitabine · interactions on record

366 records

35 severe
103 moderate
27 minor
200 info

Most severe, free to view

DicoumarolB01AA01severe
WarfarinB01AA03severe
Folic acidB03BB01severe
CladribineL01BB04severe

1 more interaction with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Capecitabine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All capecitabine products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

Austria · Capecel, Capecitabin Sandoz
Bulgaria · Капецитабин Алуфарма, Капецитабин Зентива К.С
Cyprus · Capecitabine Koanaa 150mg, Capecitabine Koanaa 500mg
Czechia · Capecitabine, Capecitabine Pharmagen
Germany · Capecitabin Al, Capecitabin Amarox
Denmark · Capecitabin Stada, Capecitabin Zentiva
Estonia · Capecitabine Zentiva, Capecitabine Zentiva K.S.
Spain · Capecitabina Glenmark, Capecitabina Kern Pharma
Finland · Capecitabine Orion
France · Capecitabine Arrow, Capecitabine Biogaran
United Kingdom (Northern Ireland) · Capecitabine Amarox, Capecitabine Dr. Reddy's
Greece · Capecitabine Mylan, Capibine
Croatia · Kapecitabin Jgl 500 Mg, Kapecitabin Sandoz
Hungary · Capecitabin Onkogen, Capecitabine Pharmacenter
Iceland · Capecitabine Accord, Capecitabine Medac
Italy · Capecitabina Mylan, Capecitabina Zentiva
Liechtenstein · Capecitabine Accord, Capecitabine Medac
Lithuania · Capecitabine Zentiva, Capecitabine Zentiva K.S.
Latvia · Capecitabine Zentiva, Capecitabine Zentiva K.S.
Malta · Capecitabine Pharmacare, Kapetral
Norway · Capecitabine Accord, Capecitabine Medac
Poland · Capecitabine Glenmark
Portugal · Capecitabina Aurovitas, Capecitabina Farmoz
Romania · Capecitabină Dr. Reddy's, Cerex
Sweden · Capecitabin Stada, Capecitabine Orion
Slovenia · Kapecitabin Fresenius Kabi
Slovakia · Capecitabine Pharmacenter, Capecitabine Pharmagen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/d6acfeae-51ff-450d-a260-1185ef8628a2
GET /v1/drugs/d6acfeae-51ff-450d-a260-1185ef8628a2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h109393_smpc.pdf",
  "strength": null,
  "atc_label": "Capecitabine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg109393",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "HYPROMELLOSE (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ROOD  (E 172)",
    "LACTOSE 0-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "CAPECITABINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h109393.pdf",
  "authorised_at": "2012/03/21",
  "procedure_number": "NL/H/2287/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "109393",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about capecitabine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console